-

Hims & Hers Expands Women’s Health Offerings With Support For Urinary Tract Health

D-Mannose powder packets are one of the latest offerings, furthering company’s mission to provide more access, ease and personalization to solutions for women’s health needs

SAN FRANCISCO--(BUSINESS WIRE)--Hims & Hers Health, Inc. (“Hims & Hers”, NYSE: HIMS), the multi-specialty telehealth platform focused on providing modern personalized health and wellness experiences to consumers, recently expanded its women’s health offerings with the recent launch of a D-Mannose dietary supplement powder to support urinary tract health on ForHers.com. This most recent holistic offering reiterates the company’s mission to provide consumers with products - both over the counter and prescription, as recommended by medical practitioners - access to the health solutions they need without the hassles accompanied by traditional methods.

“Roughly 3 or 4 in 10 women who experience an initial urinary tract infection (UTI) will face another one within six months. There’s a clear need for ways to be proactive about urinary tract health,” said Hilary Coles, co-founder and SVP of Brand & Innovation, Hims & Hers. “It is important to have holistic, over the counter options to promote the various elements of women’s health, which is why we are now offering these tasty single-serve packets formulated with vitamins and electrolytes that have been shown to help maintain urinary tract balance.”

The powder, which comes in packages of 10 cranberry-raspberry flavored single-serve packets, supports a healthy urinary system with a combination of D-Mannose, a sugar found in cranberry juice, three electrolytes (calcium, magnesium and potassium) and antioxidants (vitamins C and B6). Consumers can purchase as part of a discounted subscription or as a one-time purchase.

In addition to the UT powder, the company offers a wide variety of sexual health products and services including access to treatment for erectile dysfunction, premature ejaculation, genital herpes and cold sores, condoms and lubricants, vibrators and birth control pills, as well as a variety of wellness supplements including unflavored collagen protein powder, and biotin gummies. For more information about the D-Mannose Powder, please visit www.forhers.com/sexual-health/ut-powder.

About Hims & Hers

Hims & Hers is a multi-specialty telehealth platform that connects consumers to licensed healthcare professionals, enabling them to access high-quality medical care for numerous conditions related to primary care, mental health, sexual health, dermatology, and more. Launched in November 2017, the company also offers thoughtfully created and curated health and wellness products. With products and services available across all 50 states and Washington, D.C., Hims & Hers is able to provide access to quality, convenient and affordable care for all Americans. Hims & Hers was founded by CEO Andrew Dudum, Hilary Coles, Jack Abraham and Joe Spector at venture studio Atomic in San Francisco, California. For more information about Hims & Hers, please visit forhims.com and forhers.com.

Contacts

Linda O'Connor
press@forhims.com

Hims & Hers Health, Inc.

NYSE:HIMS

Release Summary
Hims & Hers recently expanded its women’s health offerings with the launch of a D-Mannose dietary supplement powder to support urinary tract health.
Release Versions

Contacts

Linda O'Connor
press@forhims.com

More News From Hims & Hers Health, Inc.

Hims & Hers Chief Accounting Officer, Irene Becklund, Announces Departure from the Company

SAN FRANCISCO--(BUSINESS WIRE)--Hims & Hers Health, Inc. (NYSE: HIMS), the leading health and wellness platform, today announced its Chief Accounting Officer, Irene Becklund will depart the company after more than seven years, effective October 9, 2026. Becklund will then serve as an advisor to the company for several months to assist with the transition. The company will conduct a search for her permanent successor, with Yemi Okupe, CFO of Hims & Hers, assuming the responsibilities of...

Hims & Hers to Announce Second Quarter 2026 Financial Results on August 10, 2026

SAN FRANCISCO--(BUSINESS WIRE)--Hims & Hers Health, Inc. (“Hims & Hers”, NYSE: HIMS), the leading health and wellness platform, today announced that it will report second quarter 2026 financial results after the market closes on Monday, August 10, 2026. The company will host a live conference call to discuss the results at 5:00 p.m. ET the same day. The conference call can be accessed by dialing (888) 510-2630 for U.S. participants and (646) 960-0137 for international participants, refe...

Hims & Hers Names Dr. Anant Vinjamoori as Chief Medical Officer of Hims

SAN FRANCISCO--(BUSINESS WIRE)--Hims & Hers Health, Inc. (NYSE: HIMS), the leading health and wellness platform, today announced Dr. Anant Vinjamoori is joining as the Chief Medical Officer of the Hims brand. As the company reimagines how everyone can access proactive, comprehensive care that helps them feel great, Dr. Vinjamoori will provide the clinical guidance that shapes the next phase of the Hims brand across sexual health, hormone health, dermatology, weight loss, and mental health,...
Back to Newsroom